FDA NDA · NDA219617
TRABECTEDIN
Sponsor: EVER
What this page does not claim
A drug page is a reference view of public FDA data (Drugs@FDA), reproduced as published. SPEQ is not affiliated with the FDA, adds no interpretation to the record, and nothing here is medical, legal, or regulatory advice.
APPLICATION
NDA219617
TYPE
NDA
ORIGINAL APPROVAL
2026-10-01
LATEST ACTION
2026-10-01
ROUTE
INTRAVENOUS
DOSAGE FORM
POWDER
MARKETING STATUS
Prescription
Products
TRABECTEDIN · ReferencePrescription
TRABECTEDIN 1MG/VIAL · POWDER · INTRAVENOUS
Approval history
Source: FDA Drugs@FDA. Browse every approval SPEQ tracks →